A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)

Condition:   Congestive Heart FailureInterventions:   Drug: furosemide/no spironolactone;   Drug: metolazone/no spironolactone;   Drug: furosemid/spironolactone;   Drug: metolazone/spironolactoneSponsors:   Yonsei University;   Yonsei UniversityRecruiting - verified March 2013

Source: ClinicalTrials.gov - March 20, 2013 Category: Research Source Type: clinical trials